Buy & Sell Amphastar Pharmaceuticals Inc (AMPH) – Amphastar Pharmaceuticals Inc Price Today
Key Stats
- $829.39MMarket Cap
- HealthSector
- -29.8%3M Drawdown
- $1.22BEnterprise Value
- -Dividend Yield
- 12 daysTypical Hold Time
Amphastar Pharmaceuticals Inc (AMPH) is currently valued at a market capitalization of $829.39M, with an enterprise value of $1.22B. Over the past 52 weeks, Amphastar Pharmaceuticals Inc has traded between a low of $16.87 and a high of $30.81, highlighting its annual price range. Over the past three months, Amphastar Pharmaceuticals Inc has recorded a drawdown of -29.8%, reflecting recent price volatility. On average, investors hold Amphastar Pharmaceuticals Inc for approximately 12 days, indicating typical investor behavior on the platform.
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Most Recent News
Pepeto presale closes fast with $10.29M raised ahead of major exchange listing, outshining Cardano's slow recovery.
Pepeto's presale raised $10.29 million rapidly, signaling strong investor interest before its major exchange listing. This surge contrasts with Cardano (ADA), which remains near six-year lows around $0.17 despite recent catalyst events like Hoskinson...

New Ethereum-based crypto Pepeto presale hits $10M, promising Dogecoin-like gains with live DeFi products.
Pepeto, a new Ethereum-based cryptocurrency, has confirmed progress on its DeFi tools and surpassed $10.28 million in its presale. The project draws comparisons to Dogecoin's early success but offers working products including a DeFi exchange and cro...

Invesco QQQ Trust offers broad AI-driven tech exposure with strong 2026 growth and easy single-ticker access.
The Invesco QQQ Trust provides investors a single ticker to access the top 100 largest non-financial Nasdaq companies, heavily weighted in AI and tech leaders like NVIDIA, Microsoft, and Apple. It has delivered strong returns, up over 20% year-to-dat...
